| GTO ID | GTC0737 |
| Trial ID | ChiCTR1800016294 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Suspended |
| Title | Withdraw by the investigator The clinical study on the treatment of CD19 positive recurrence refractory b-cell acute lymphoblastic leukemia with chimeric antigen receptor T cells. |
| Year | 2018 |
| Country | China |
| Company sponsor | Affiliated Second Hospital of Dalian Medical University |
| Cohort 1 | |||||||
|
|||||||